<p style="text-align: left;"> </p> <p><strong><span data-contrast="auto">About Parabilis Medicines</span></strong><span data-ccp-props="{"134233117":false,"134233118":false,"201341983":0,"335551550":1,"335551620":1,"335559685":0,"335559737":0,"335559738":0,"335559739":0,"335559740":259}"> </span></p> <p><span data-contrast="none">Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important targets long considered undruggable. The company has pioneered a new class of alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that have historically been beyond the reach of conventional medicines. The company’s lead investigational medicine, zolucatetide, is the first and only direct inhibitor of the β-catenin:TCF interaction, a central node in the Wnt/β-catenin pathway that has eluded drug developers for decades. Zolucatetide is being evaluated in the clinic across multiple Wnt/β-catenin-driven diseases, including desmoid tumors, familial adenomatous polyposis (FAP) and a range of other solid tumor indications. Beyond zolucatetide, Parabilis is advancing additional Helicon-based programs focused on other challenging targets where we believe our medicines could have life-altering impact. For more information, visit </span><a href="https://url.us.m.mimecastprotect.com/s/gYX5CkRVZgtkknDEuVhmcGHXzh?domain=parabilismed.com/"><span data-contrast="none"><span data-ccp-charstyle="Hyperlink">www.parabilismed.com</span></span></a><span data-contrast="none"> or follow us on </span><a href="https://url.us.m.mimecastprotect.com/s/7qd3ClYV50H11oWrFyinczUQak?domain=linkedin.com"><span data-contrast="none"><span data-ccp-charstyle="Hyperlink">LinkedIn</span></span></a><span data-contrast="none">.</span><span data-ccp-props="{"335551550":6,"335551620":6}"> </span></p> <p><strong>What’s the opportunity?</strong></p> <p>Parabilis Medicines, Inc. is seeking a highly motivated and business-oriented Corporate Attorney to join the Legal team. This is a broad, hands-on role for a Corporate Attorney who can lead core public-company and corporate matters while flexing across strategic transactions, commercial contracting, manufacturing and supply arrangements, and other legal needs as the company and its programs evolve.. The Corporate Attorney will partner closely with cross-functional teams to support corporate governance, transactional matters in R&D and across the business, compliance initiatives, intellectual property matters, and strategic business development while helping mitigate legal risk and enable business growth in a fast-paced biotechnology environment.</p> <p><strong>Key Responsibilities:</strong></p> <ul> <li>Support corporate governance activities for a publicly traded company, including preparation of board and committee materials, resolutions, minutes, corporate records, entity management, corporate governance guidelines, committee charters, and the annual meeting and proxy statement process.</li> <li>Support compliance with U.S. securities laws, including preparation and/or review of SEC periodic and current reports (Forms 10-K, 10-Q, and 8-K), proxy statements, and registration statements, and assist with Section 16 reporting obligations, including Forms 3, 4, and 5, for officers, directors, and other insiders.</li> <li>Advise on compliance with the Securities Act of 1933 and the Securities Exchange Act of 1934, Nasdaq listing standards, Regulation FD, and the company's insider trading policy, and support the administration of trading windows and pre-clearance procedures.</li> <li>Advise on equity compensation programs and executive compensation matters, including related Section 16 and public disclosure implications, in partnership with Human Resources and Finance.</li> <li>Support public and private securities offerings, capitalization matters, and related corporate transactions, and assist with the preparation and review of earnings releases, investor presentations, and other public disclosure materials in coordination with Finance and Investor Relations.</li> <li>Draft, review, negotiate, and manage a wide variety of commercial agreements, including confidentiality agreements, master service agreements, statements of work, consulting agreements, clinical trial agreements, vendor and supplier agreements, agreements with contract development and manufacturing organizations (CDMOs) and other manufacturing and supply partners, software and SaaS agreements, collaboration and licensing agreements, material transfer agreements, and sponsored research agreements.</li> <li>Provide legal support for licensing, collaborations, partnerships, investments, acquisitions, and other strategic transactions, including due diligence, and manage relationships with U.S. and international outside counsel on cross-border transactions, clinical research, intellectual property, privacy, and local law matters.</li> <li>Advise business partners on healthcare compliance, privacy, anti-corruption, and other laws and regulations applicable to a pharmaceutical and biotechnology company.</li> <li>Partner with Business Development on the structuring, diligence, negotiation, and execution of strategic transactions, including licensing, collaboration, co-development, and other partnering arrangements, from term sheet through definitive agreements.</li